RTX (RTX) Q1 2026 Earnings Call Transcript

RTX reported strong Q1 results with adjusted sales of $22.1 billion (+10% organic), adjusted EPS of $1.78 (+21%), and free cash flow of $1.3 billion, while backlog hit a record $271 billion, up 25% year over year. Management raised full-year adjusted sales guidance to $92.5 billion-$93.5 billion and EPS guidance to $6.70-$6.90, driven by robust defense demand, higher Raytheon awards, and improving Pratt & Whitney GTF output. The call also highlighted nearly $900 million of capacity investments, 1.14 book-to-bill, and ongoing tariff and supply-chain risks, but the overall tone was clearly constructive.

Analysis

RTX is increasingly behaving like a capacity-constrained defense compounder rather than a cyclical aerospace supplier. The key second-order effect is that framework agreements and replenishment demand will force a multi-year capital cycle across the supply base, which should widen the moat for prime contractors with balance-sheet capacity and in-house manufacturing depth. That dynamic is bullish for RTX relative to smaller missile peers that may have demand but lack the tooling, labor pipeline, and supplier leverage to monetize it at scale.

The market may still be underestimating the mix shift inside Raytheon: a larger share of sales tied to effectors and sensors means higher visibility, but also more exposure to bottlenecks in rocket motors, microelectronics, and specialty materials. That bottleneck is not just a risk to near-term growth; it is a bargaining chip that can push pricing and contract structure in RTX’s favor over the next 6-18 months as the supply chain requires firm demand signals to fund expansion. The more the company can convert episodic demand into framework-based capacity commitments, the more durable the margin profile becomes.

On Pratt, the headline is not just aftermarket recovery; it is that the company is effectively shifting the earnings mix toward a heavier, higher-margin installed-base monetization model while managing OE dilution. The GTF repair cycle is likely to be a multi-quarter margin tailwind as shop visits get heavier and output increases, but the bridge from AOG reduction to normalized engine economics is uneven and can be delayed by any supplier hiccup or airline pushback on slot allocation. Collins looks steadier, but its upside is less obvious unless widebody ramp and interiors recovery hold through a softer macro travel backdrop.

Contrarianly, the strongest consensus risk is that investors focus on defense demand as already priced while missing the supply-chain industrialization story. If RTX executes, the market may re-rate the name on backlog quality and FCF durability, not just top-line growth. The main reversal catalyst is not demand destruction; it is a failure to convert demand into shipments because one or two critical sub-tier suppliers fail to scale on time.

Key Decisions for Investors

• Long RTX common over 3-6 months on pullbacks; upside comes from guide credibility plus backlog monetization, while the main risk is execution slippage in munitions supply chain
• Pair trade: long RTX / short LHX for 6-12 months; RTX has clearer visibility into backlog conversion and a stronger near-term defense mix tailwind, while LHX is more vulnerable to program timing and less direct benefit from munitions replenishment
• Sell put spreads on RTX 1-2 quarters out if implied volatility is elevated; the stock has an earnings-supported floor from guidance raises and free cash flow support, but supply-chain headlines can still create entry points
• Avoid chasing RTX after sharp defense headlines; better entry is on any 5-8% pullback tied to tariff or airline-demand noise, since neither appears to alter the core earnings trajectory over the next 2-3 quarters
• Monitor RTX vs aerospace OEMs for a relative-value long: RTX should outperform names more exposed to short-cycle commercial demand if air-travel growth softens, because defense and aftermarket cash flows are buffering the cycle